Potassium Citrate Tablet, Extended Release
Product Images NDC 31722-129

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 31722-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

10 Meq-100s (10 Meq 100s)

10 Meq-100s (10 Meq 100s)
FDA Label Image

15 Meq-100s (15 Meq 100s)

15 Meq-100s (15 Meq 100s)
Potassium Citrate Extended-Release Tablets, USP are a prescription medication in a 100 tablet package. The tablets are oval-shaped and off-white to tan-yellowish in color. Each 15 mEq tablet is debossed with ‘T’ on one side and ‘401” on the other side. It is recommended to read the package insert for dosage information. These tablets are manufactured by Ascent Pharmaceuticals, Inc. in Central Islip, NY 11722, for Camber Pharmaceuticals, Inc. in Piscataway, NJ 08854. They must be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F).*
FDA Label Image

5 Meq-100s (5 Meq 100s)

5 Meq-100s (5 Meq 100s)
This is a description of a prescription drug with the NDC code 31722-129-01. The drug is called Potassium Citrate Extended-Release Tablets, USP and each tablet contains 5 mEq (540 mg) of potassium citrate. This medication is used to treat certain types of kidney stones. The tablets are uncoated, round and either white or tan/yellowish in color. The label recommends storing the drug in a light container with consistent sealing, between temperatures of 20°C to 25°C. This medication is dispensed in batches of 100 tablets, with dosage information contained in the package insert. The manufacturer is Ascent Pramaceuticals, located in Central Islip, NY, and the pharmaceutical company Camber Pharmaceuticals located in Piscataway, NJ.*
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Table 1.

Table 1.
The text presents a table showing the effect of Potassium Citrate in patients with Calcium Oxalate Nephrolithiasis. The table shows the number of stones formed per year for each group before and during treatment with Potassium Citrate. The table also includes the percentage of patients in each group who experienced remission (remaining free of newly formed stones during treatment) and any decrease in stones formed.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.